Researchers recently discovered that half (50%) of all Organ Transplant Recipients in a particular study failed to produce antibodies when tested after being administered two Doses of the experimental “Coronavirus” or “MERS” vaccine. In some cases, the recipients produced no antibodies at all after being given two doses of the experimental “Coronavirus” or MERS Vaccine and receiving a kidney transplant.
This is according to a study titled Coronavirus Infection in Kidney Transplant Recipients Studied by Serum Antibody Analysis by a team of researchers at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.
Noteworthy, the study was conducted on kidney transplant recipients; and not on general public members of society. The researchers pointed out that some organ recipients are better at producing antibodies after being vaccinated than others.
Despite organ transplant recipients showing low production or lack of antibodies, after being administered the Coronavirus vaccine; the researchers concluded that two doses are still more effective than one dose.
